Xilio Therapeutics Financial Overview
Xilio Therapeutics's market cap is currently $34.13M. The company's EPS TTM is $-0.11; its P/E ratio is -0.99; Xilio Therapeutics is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.07. See an overview of income statement, balance sheet, and cash flow financials.
